Avita Medical Projects Substantial Revenue Growth for FY26

Avita Medical projects FY26 revenue of $80-$85 million, up from $71.6 million in FY24, driven by its innovative burn treatment devices. Despite poor financial strength and high volatility, the company's flagship product, RECELL system, has approval in several international markets and is being rolled out across US burn centers. Analysts are cautiously optimistic, with a recommendation score of 2.2 and a target price of $6.9.